Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CASH FLOWS

v3.21.1
CONDENSED STATEMENT OF CASH FLOWS
3 Months Ended
Mar. 31, 2021
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (4,461,996)
Adjustments to reconcile net loss to net cash used in operating activities:  
Net gain from investments held in Trust Account (3,388)
Change in fair value of derivative warrant liabilities 3,305,000
Financing cost - derivative warrant liabilities 821,170
Changes in operating assets and liabilities:  
Prepaid expenses (540,441)
Accounts payable 223,322
Accounts payable - related party 30,000
Accrued expenses 14,358
Net cash used in operating activities (611,975)
Cash Flows from Investing Activities:  
Proceeds deposited in Trust Account (414,000,000)
Net cash used in investing activities (414,000,000)
Cash Flows from Financing Activities:  
Proceeds received from initial public offering, gross 414,000,000
Proceeds from private placement 10,280,000
Repayment of notes payable to related party (185,116)
Offering costs paid (8,715,099)
Net cash provided by financing activities 415,379,785
Net Change in Cash 767,810
Cash - beginning of the period 6,410
Cash - end of the period 774,220
Supplemental disclosure of noncash investing and financing activities:  
Offering costs included in accrued expenses 85,000
Offering costs included in notes payable 45,167
Deferred underwriting commissions in connection with the initial public offering 14,490,000
Class A Common Stock Subject to Redemption  
Supplemental disclosure of noncash investing and financing activities:  
Initial value of ordinary shares subject to possible redemption 395,556,560
Change in value of ordinary stock subject to possible redemption $ (24,757,570)